Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Recent evidence supports the use of GLP-1 RAs in patients with obesity-related HFpEF
They used moderate concentrations rather than jumping to the highest available
Regular follow-up appointments allow for monitoring of weight loss velocity and assessment of any developing symptoms
Adan, GLP-1 receptor agonist GLP1-S reduces appetite while increasing dopamine reward signaling, Neuroscience Applied, Volume 3, 2024, 103925, ISSN 2772-4085
For them, starting a GLP1 can be the first time they experience that sensation. Do GLP-1s work differently in women and men
Tirzepatide: A GIP/GLP-1 Dual Agonist for MASH. The New England Journal of Medicine , 2024, www.nejm.org/doi/full/10.1056/NEJMoa2401943
